|
Background
|
p27Kip1 is a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. This protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state.
|
Background
References
|
- Kawamata, N., et al., Eur. J. Haematol. 74(5):424-429 (2005).
- Andreu, E.J., et al., Cancer Res. 65(8):3264-3272 (2005).
- Wingate, H., et al., J. Biol. Chem. 280(15):15148-15157 (2005).
- Wang, C., et al., J. Biol. Chem. 280(13):12339-12343 (2005).
- Rassidakis, G.Z., et al., Blood 105(2):827-829 (2005).
|
Order Information
List Price (USA): $235.00/0.1mg
Related Products
Data Rewards Program
